Feugiat nulla facilisis at vero eros et curt accumsan et iusto odio dignissim qui blandit praesent luptatum zzril.
+ (123) 1800-453-1546
info@example.com

Related Posts

Products

AFP

The Biorex Diagnostics AFP Rapid Test Device (Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of AFP in serum or plasma to aid in the diagnosis of Hepatocellular Carcinoma or foetal open neural tube defects.

Alpha-Fetoprotein (AFP) is normally produced during foetal and neonatal development by the liver, yolk sac and in small concentrations by the gastrointestinal tract. By the second year of life, AFP concentrations decrease rapidly, and thereafter only trace amounts are normally detected in serum. In general, normal adults have serum AFP concentrations of less than 10 ng/ml. Elevated AFP levels occur in several malignant diseases including hepatocellular carcinoma, testicular nonseminomatous origin, and occasionally of other entodermal origin. AFP has also been used to detect early tumours in people at high risk for liver cancer.

Add to Quote

Description

Product Name CAT.No Size
AFP AFPC0040 40T

 

 

Product Description

The Biorex Diagnostics AFP Rapid Test Device is a rapid, chromatographic immunoassay for the qualitative detection of Alpha-Fetoprotein (AFP) in human serum or plasma. It provides fast and reliable results to support the diagnosis of hepatocellular carcinoma (HCC), monitoring of high-risk patients, and prenatal screening for foetal open neural tube defects.

Key Features
• Rapid chromatographic immunoassay – provides visual qualitative detection within minutes
• Compatible with serum or plasma – minimal sample volume required
• High sensitivity and specificity – reliable identification of abnormal AFP levels
• Quick and convenient – ideal for point-of-care testing and clinical laboratories
• Versatile applications – supports tumour monitoring, high-risk patient screening, and maternal-foetal health assessment

Benefits
Use of the AFP Rapid Test Device enables early detection of hepatocellular carcinoma and other AFP-related conditions, facilitates monitoring of high-risk patients, and supports prenatal screening for foetal neural tube defects. Its rapid, ready-to-use format, ease of use, and reliable performance enhance clinical workflow, improve patient care, and provide a cost-effective solution for timely AFP detection.

Additional information

Storage

2-8°C